AllianceBernstein’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-375,300
| Closed | -$19.7M | – | 3262 |
|
|
2020
Q3 | $19.7M | Buy |
375,300
+92,921
| +33% | +$3.85M | 0.01% | 805 |
|
|
2020
Q2 | $9.39M | Buy |
282,379
+30,120
| +12% | +$959K | 0.01% | 1029 |
|
|
2020
Q1 | $6.86M | Buy |
252,259
+89,120
| +55% | +$2.48M | ﹤0.01% | 1049 |
|
|
2019
Q4 | $3.22M | Buy |
163,139
+3,443
| +2% | +$55.1K | ﹤0.01% | 1682 |
|
|
2019
Q3 | $2.07M | Sell |
159,696
-18,600
| -10% | -$225K | ﹤0.01% | 1896 |
|
|
2019
Q2 | $2.22M | Buy |
178,296
+40,100
| +29% | +$532K | ﹤0.01% | 1913 |
|
|
2019
Q1 | $2.01M | Buy |
138,196
+11,800
| +9% | +$151K | ﹤0.01% | 1897 |
|
|
2018
Q4 | $1.4M | Hold |
126,396
| – | – | ﹤0.01% | 2031 |
|
|
2018
Q3 | $3.32M | Hold |
126,396
| – | – | ﹤0.01% | 1572 |
|
|
2018
Q2 | $2.58M | Buy |
126,396
+15,909
| +14% | +$341K | ﹤0.01% | 1746 |
|
|
2018
Q1 | $2M | Buy |
110,487
+1,191
| +1% | +$19.9K | ﹤0.01% | 1816 |
|
|
2017
Q4 | $1.52M | Hold |
109,296
| – | – | ﹤0.01% | 2035 |
|
|
2017
Q3 | $2.02M | Hold |
109,296
| – | – | ﹤0.01% | 1840 |
|
|
2017
Q2 | $1.85M | Buy |
109,296
+17,800
| +19% | +$271K | ﹤0.01% | 1915 |
|
|
2017
Q1 | $1.22M | Sell |
91,496
-5,700
| -6% | -$89.3K | ﹤0.01% | 2142 |
|
|
2016
Q4 | $1.46M | Hold |
97,196
| – | – | ﹤0.01% | 2052 |
|
|
2016
Q3 | $1.14M | Hold |
97,196
| – | – | ﹤0.01% | 2156 |
|
|
2016
Q2 | $1.05M | Hold |
97,196
| – | – | ﹤0.01% | 2187 |
|
|
2016
Q1 | $898K | Hold |
97,196
| – | – | ﹤0.01% | 2162 |
|
|
2015
Q4 | $1.44M | Hold |
97,196
| – | – | ﹤0.01% | 1877 |
|
|
2015
Q3 | $1.59M | Buy |
97,196
+560
| +0.6% | +$11.5K | ﹤0.01% | 1833 |
|
|
2015
Q2 | $2.2M | Buy |
96,636
+15,200
| +19% | +$303K | ﹤0.01% | 1708 |
|
|
2015
Q1 | $1.24M | Hold |
81,436
| – | – | ﹤0.01% | 2079 |
|
|
2014
Q4 | $980K | Hold |
81,436
| – | – | ﹤0.01% | 2211 |
|
|
2014
Q3 | $923K | Sell |
81,436
-3,400
| -4% | -$38.8K | ﹤0.01% | 2243 |
|
|
2014
Q2 | $1.02M | Sell |
84,836
-510,379
| -86% | -$6.03M | ﹤0.01% | 2243 |
|
|
2014
Q1 | $6.93M | Sell |
595,215
-594,905
| -50% | -$10.1M | 0.01% | 985 |
|
|
2013
Q4 | $21M | Sell |
1,190,120
-47,648
| -4% | -$801K | 0.02% | 652 |
|
|
2013
Q3 | $17.8M | Buy |
1,237,768
+1,098,796
| +791% | +$16.8M | 0.02% | 680 |
|
|
2013
Q2 | $2.09M | Buy |
+138,972
| New | +$1.83M | ﹤0.01% | 1576 |
|
AllianceBernstein's MNTA Position: Q4 2020 in Review
AllianceBernstein sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 375,300 shares — an estimated $19.7M sold.
AllianceBernstein first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $21M in Q4 2013. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- AllianceBernstein reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- AllianceBernstein sold 375,300 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $19.7M.
- AllianceBernstein first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- AllianceBernstein's Momenta Pharmaceuticals, Inc. position peaked at $21M in Q4 2013.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on AllianceBernstein's 13F filing for Q4 2020, filed 8 Feb 2021.